Analysis of radiation therapy quality assurance in NRG Oncology RTOG 0848
CONCLUSION: One-third of patients required resubmission to meet protocol compliance criteria, demonstrating the continued need for expending resources on real-time, pretreatment QA in trials evaluating the use of radiotherapy, particularly for pancreas cancer. Rigorous QA is critically important for clinical trials involving RT to ensure that the true impact of RT is assessed. Moreover, RT QA serves as an educational process through providing feedback from specialists to practicing radiation oncologists on best practices.PMID:37598723 | DOI:10.1016/j.ijrobp.2023.08.014
Source: Health Physics - Category: Physics Authors: Leila T Tchelebi Kathryn A Winter Ross A Abrams Howard P Safran William F Regine Susan McNulty Abraham Wu Kevin L Du Samantha A Seaward Shelly X Bian Raid Aljumaily Anand Shivnani Timothy D Moore Todd S Crocenzi Thomas A DiPetrillo Adam R Kuykendal Christ Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Education | Intensity-Modulated Radiation Therapy | Pancreas | Pancreatic Cancer | Physics | Radiation Therapy | Study